US EditionKIST Engineers Versatile Peptide to Combat Viruses and Accelerate Wound
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
KIST Engineers Versatile Peptide to Combat Viruses and Accelerate Wound
A groundbreaking advancement in antiviral therapeutics and regenerative medicine has emerged from the Korea Institute of Science and Technology (KIST), where researchers have developed a bioactive peptide derived from a native human protein with potent dual functionality. This peptide metabolite, named Ac-Tβ1-17, originates from thymosin β4, a naturally occurring protein recognized for its role in cellular processes. The research offers transfor…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
